Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
Citation:
BMC Pharmacology
2009
9(Suppl 1):S1
Volume 9 Supplement 1
Regensburg, Germany19-21 June 2009
Page 1 of 3